Thomas Kronbach
Founder at elbion NV
Profile
Thomas Kronbach is the founder of elbion NV, a company founded in 2002, where he currently holds the title of Chief Scientific Officer.
He also has former positions as Chief Scientific Officer at Biotie Therapies Oy, Principal at The Scripps Research Institute, Head-Research at elbion AG from 2002 to 2007, and Principal at AMW GmbH from 1992 to 2009.
Thomas Kronbach active positions
Companies | Position | Start |
---|---|---|
elbion NV
elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Founder | 24/12/2009 |
Former positions of Thomas Kronbach
Companies | Position | End |
---|---|---|
elbion AG
elbion AG Miscellaneous Commercial ServicesCommercial Services elbion AG discovers and develops new small molecule drugs for the treatment of inflammatory and central nervous system diseases with high unmet medical need. It's lead product candidate AWD 12-281 is a topical inhibitor and is in phase IIa trials for the treatment of chronic obstructive pulmonary disease and has licensed it to GlaxoSmithKline for exclusive development and commercialization. It focuses on target areas, including PDE inhibitors and CNS modulators, in terms of novel chemistries, novel assays and mechanisms of action, as well as in-house animal disease models. Founded in 2002, the company is headquartered in Radebeul, Germany. | Chief Tech/Sci/R&D Officer | 22/06/2007 |
BIOTIE THERAPIES CORP | Chief Tech/Sci/R&D Officer | - |
AMW GmbH
AMW GmbH Pharmaceuticals: MajorHealth Technology AMW GmbH engages in the development and marketing of medicines, cosmetics, and medical devices. The company was founded by Wilfried Fischer on July 9, 2008 and is headquartered in Warngau, Germany. | Chief Tech/Sci/R&D Officer | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
elbion NV
elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Health Technology |
Biotie Therapies Oy
Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
elbion AG
elbion AG Miscellaneous Commercial ServicesCommercial Services elbion AG discovers and develops new small molecule drugs for the treatment of inflammatory and central nervous system diseases with high unmet medical need. It's lead product candidate AWD 12-281 is a topical inhibitor and is in phase IIa trials for the treatment of chronic obstructive pulmonary disease and has licensed it to GlaxoSmithKline for exclusive development and commercialization. It focuses on target areas, including PDE inhibitors and CNS modulators, in terms of novel chemistries, novel assays and mechanisms of action, as well as in-house animal disease models. Founded in 2002, the company is headquartered in Radebeul, Germany. | Commercial Services |
AMW GmbH
AMW GmbH Pharmaceuticals: MajorHealth Technology AMW GmbH engages in the development and marketing of medicines, cosmetics, and medical devices. The company was founded by Wilfried Fischer on July 9, 2008 and is headquartered in Warngau, Germany. | Health Technology |
- Stock Market
- Insiders
- Thomas Kronbach